Organisation
Nuclear Medicine
Current researchers
1 - 10 of 35 results
- Simon Arits (Member)
- Jesse Asiedu (Member)
- Kelly Boumon (Member)
- Sophie Bourgeois (Member)
- Amelientje Bracke (Member)
- Vicky Caveliers (Member)
- Veerle De Grove (Member)
- Lynn De Mey (Member)
- Steffi De Trif (Member)
- Jens Debacker (Member)
Projects
1 - 7 of 7
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE).From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Development of a novel chemoenzymatic technology to generate radiofluorinated PET tracersFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
- SBO project: Nanobody Life Time imaging to Enhance Surgery (NLITESurgery)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research (SBO)
- H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspects (OZR EU BONUS)From1 Sep 2020 → 31 Aug 2023Funding: BOF - mobility
- H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspectsFrom1 Sep 2020 → 31 Aug 2023Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Jan 2020 → TodayFunding: IOF - technology validation in real environment, IOF - mandates
- Connect 2018: IMMUNE-IMAGE: Specific Imaging of Immune Cell Dynamics Using Novel Tracer StrategiesFrom10 Oct 2018 → 11 Dec 2018Funding: Brussels Capital Region
Publications
101 - 105 of 105
- A versatile T cell-based assay to assess therapeutic antigenspecific PD-1-targeted approaches(2018)
Authors: Maarten Versteven, Johan M.J. Van den Bergh, Katrijn Broos, Fumihiro Fujiki, Diana Campillo-Davo, Hans De Reu, Soyoko Morimoto, Quentin Lecocq, Marleen Keyaerts, Zwi Berneman, et al.
Pages: 27797-27808 - Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series(2023)
Authors: Jens Tijtgat, Evan Maarten Calliauw, Iris Dirven, Manon Vounckx, Randa Kamel, A Vanbinst, Hendrik Everaert, Laura Seynaeve, Dirk Van Den Berge, Johnny Duerinck, et al.
- Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α-Particle Therapy of Cancer(2018)
Authors: Marek Pruszynski, Matthias D'Huyvetter, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte
Pages: 1457-1466 - The Prognostic Value of CD206 in Solid Malignancies(2021)
Authors: Jens Debacker, Odrade Gondry, Tony Lahoutte, Marleen Keyaerts, Wouter Huvenne
- Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies(2020)
Authors: Janik Puttemans, Yana Dekempeneer, Jos Leon Eersels, Heleen Hanssens, Pieterjan Debie, Marleen Keyaerts, Karine Breckpot, Quentin Lecocq, Tony Lahoutte, Albert D Windhorst, et al.